The first part, the peptide, is the cornerstone in our technology. It has two intrinsic functions. First, it delivers the disease-specific protein to an important cell of the immune system. Second, it renders these cells into a “tolerogenic cell” that drives inhibitory cells. The protein in two-component therapy is easily exchangeable and can be adapted for different organ-specific autoimmune diseases.